CJASN @CJASN Twitter profile

Last Seen Profiles

@herisprincess

@WilkoszWiktoria

@lolhiphop

@football_rivers

@MiNimmm2006

@NehemiahVann

@Volunteer_Blue

@FrenteRenovador

@stw_pdg

@LINA_KECIL

@BinorRaja

@MiNimmm2006

@RealTomPetrini

@BDsbg47718

@genome_gov

@HassanMilikin

@JongsTian

@yannickmassilia

@VronikaTheWitch

@McchesneyDanny

@ayan_khan30393

@ERASMUSHESPER

@BinorRaja

@SydneyMartin_08

@mikan_chn

@Stevie_63b

@ChaseMurrayNCT

@LahriyaNixa

@strez40710

@AwetNyc

@RadcliffeJoel2

@mariapaulab16

@switchO4O3

@kaetn

@Therealvoiceo10

@nour_ea1

CJASN

@CJASN

2 years

SGLT2 inhibitors are now embedded in clinical practice guidelines to slow the progression of CKD in patients with and without diabetes mellitus. This Review discusses the kidney-protective effects of SGLT2 inhibitors

2

136

364

CJASN

@CJASN

10 months

Combination diuretic therapy is a widely applied strategy to counter renal sodium avidity. This Review discusses the results of the key studies on combination diuretic therapy in the setting of acute heart failure and their findings @AmirKazory

2

163

367

CJASN

@CJASN

9 months

The benefits of SGLT2 inhibitors in patients with CKD have been well established in major clinical trials. This Perspective examines if SGLT2 inhibitors are effective & safe in patients with severe CKD, dialysis, or kidney transplantation @StefanPBerger

5

139

357

CJASN

@CJASN

2 years

AKI is a syndrome that is often multifactorial, especially in the hospitalized patient. This Review discusses the pathophysiology of three etiologies that cause AKI: kidney hypoperfusion, abdominal compartment syndrome, & urinary tract obstruction

0

128

351

CJASN

@CJASN

2 years

SGLT2 inhibitors are a critical part of clinical practice guidelines for the management of patients with cardiovascular disease with and without diabetes. This Review discusses the mechanisms by which they act and the potential changes in kidney function

0

97

238

CJASN

@CJASN

2 years

SGLT2 inhibitors have become an integral part of clinical practice guidelines to slow CKD progression. This Review examines the mechanisms by which this class of compounds provide kidney protection and how they impact various aspects of kidney homeostasis

4

94

231

CJASN

@CJASN

1 year

The cardiorenal syndrome refers to a group of complex, bidirectional pathophysiological pathways involving dysfunction in both the heart and kidney. This Review focuses on the cardiorenal syndrome encountered in the hospital setting

1

97

229

CJASN

@CJASN

3 years

The KDIGO 2021 Clinical Practice Guideline for the Management of BP in CKD includes new recommendations on BP management for individuals with non-dialysis CKD. This Kidney Case Conference: How I Treat article presents a case that incorporates these updates

0

111

226

CJASN

@CJASN

2 years

Pseudohyperaldosteronism is a syndrome featuring hypokalemia, metabolic alkalosis and suppressed renin in the absence of elevated aldosterone levels. This Kidney Case Conference: How I Treat article presents a schema for diagnosis and management

0

90

223

CJASN

@CJASN

1 year

Fluid overload is the primary reason for admission of patients with acute heart failure. In this Review, Dr @AmirKazory provides an overview of the results of the key studies on combination diuretic therapy in the setting of acute heart failure

1

105

219

CJASN

@CJASN

1 year

The clinical benefits of SGLT2 inhibitors in patients with CKD have been well established. This Perspective explores if SGLT2 inhibitors will also be effective in patients with severe CKD, Dialysis, or Kidney Transplantation @StefanPBerger

0

94

221

CJASN

@CJASN

8 months

Rhabdomyolysis is a condition characterized by the destruction of skeletal muscle fibers and the release of intracellular contents into the bloodstream. This article discusses the management of rhabdomyolysis-induced AKI @javo_neyra

0

93

198

CJASN

@CJASN

11 months

CJASN is pleased to announce that @ConnieMRhee , MD, MSc, has been appointed Editor-in-Chief. She will begin her term on January 1, 2024. Dr. Rhee is currently a member of the CJASN Editorial Board and is the first female CJASN Editor-in-Chief. Learn more:

29

26

192

CJASN

@CJASN

4 months

Nephrologists are frequently consulted when the cause of high anion gap metabolic acidosis is not readily apparent. This article discusses the use of a modified version of the CUTE DIMPLES mnemonic in the evaluation of high anion gap metabolic acidosis

1

68

186

CJASN

@CJASN

2 months

Blood purification by dialysis is a nephrology cornerstone. This Perspective provides an update on current knowledge on hemoadsorption and describes its current use and research agenda for the future @ForniLuiG

0

80

178

CJASN

@CJASN

3 years

This study found that most patients with kidney failure undergoing hemodialysis developed a substantial antibody response after vaccination with Pfizer-BioNTech COVID-19 vaccine, but it was significantly less than that of individuals without kidney disease

5

76

170

CJASN

@CJASN

5 years

Did you miss the @CJASN special series "Glomerular Disease: Update for the Clinician "? We have you covered. Download the compiled PDF of the series here:

0

86

157

CJASN

@CJASN

1 year

Cardiorenal syndrome refers to a complex group of disorders involving dysfunction in the heart & kidneys. This article reviews the cardiorenal syndrome in the hospital setting, defined by declines in kidney function in acute decompensated heart failure

1

75

155

CJASN

@CJASN

8 months

Nephrologists are often consulted when the cause of high anion gap metabolic acidosis is not apparent. This Kidney Case Conference: How I Treat article uses a modified version of the CUTE DIMPLES mnemonic to evaluate high anion gap metabolic acidosis

1

62

151

CJASN

@CJASN

2 years

Cardiorenal syndrome is a group of bi-directional pathways involving declining heart & kidney function. This article reviews cardiorenal syndrome encountered in the hospital setting defined by declines in kidney function & acute decompensated heart failure

2

52

150

CJASN

@CJASN

6 months

"IgA nephropathy may not be that slow progressive disease we once believed it was." This Editorial discusses the long-term effects of IgA nephropathy @kdjhaveri @Joyita_4 @HofstraKidney

3

65

146

CJASN

@CJASN

6 years

Special Series- Glomerular Diseases: Update for the Clinician now available online as a downloadable single pdf file on the CJASN homepage #openaccess @rajmehrotra1122

8

103

143

CJASN

@CJASN

10 months

Tumor lysis syndrome results from the destruction of malignant cells, releasing intracellular content into the extracellular space. This Kidney Case Conference: How I Treat article discusses optimal treatment for tumor lysis syndrome

1

73

144

CJASN

@CJASN

4 months

Rhabdomyolysis is a condition characterized by the destruction of skeletal muscle fibers and the release of intracellular contents into the bloodstream. This Kidney Case Conference: How I Treat article discusses treatment of rhabdomyolysis-induced AKI

0

67

141

CJASN

@CJASN

5 years

Did you miss the @CJASN special series "Renal Physiology for the Clinician"? No problem, it's now available in a compiled PDF that you can download here:

0

69

137

CJASN

@CJASN

6 months

Intensive BP lowering in SPRINT produced decreases in kidney function & higher AKI risk. This study found intensive BP lowering was linked to a steeper slope of decline in eGFR and higher risk for kidney events during the intervention phase of the trial

1

62

137

CJASN

@CJASN

2 years

ANCA-associated vasculitides are multisystem disorders that affect the kidneys with an aggressive inflammation. In this Kidney Case Conference: How I Treat article, Drs @BrixSilke & @VladimirTesar discuss the use of rituximab in severe ANCA-associated GN

0

59

134

CJASN

@CJASN

10 months

KDIGO guidelines recommend anti-PLA2R antibody levels as a marker of treatment response in membranous nephropathy. This Podcast discusses findings that anti-PLA2R antibody levels with albumin levels after 3 months of treatment was the optimal method

0

55

137

CJASN

@CJASN

3 months

Sotagliflozin is a dual SGLT1 and 2 inhibitor that has demonstrated CV benefits. This study found sotagliflozin reduced the risk of kidney and cardiorenal composite end points in patients with type 2 diabetes and CKD @AOdutayo

2

63

135

CJASN

@CJASN

4 months

SGLT2 inhibitors are a critical component of clinical practice guidelines for cardiovascular disease management. This Review discusses changes in kidney physiology after the SGLT2 inhibitor administration predicted to cause both hypokalemia & hyperkalemia

1

51

133

CJASN

@CJASN

4 years

A review highlights knowledge gaps in the use of intravenous albumin for mitigating hypotension & augmenting ultrafiltration. It discusses the implications of hypoalbuminemia & the potential risks & benefits of intravenous albumin use for these indications

0

44

131

CJASN

@CJASN

3 years

Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy. Review looks at risk factors & treatments of SGLT2i-induced ketoacidosis in individuals with kidney disease. Precautions are discussed that can decrease likelihood of this complication

1

57

131

CJASN

@CJASN

2 months

Nonlupus full house nephropathy is a rare, complex entity. This study supports that SLE and nonlupus full house nephropathy are distinct clinical entities, with comparable outcomes @AKronbichler

2

57

130

CJASN

@CJASN

2 years

AKI is commonly encountered in patients with decompensated cirrhosis, and the burden of kidney dysfunction in this population is rising. This article discusses management of AKI in patients with liver disease @VelezNephHepato

2

60

126

CJASN

@CJASN

11 months

The role of albumin in kidney injury remains controversial. Is it a marker of advancing glomerular injury, a marker of proximal tubule injury and dysfunction, or a combination of both? This Perspective examines studies on the kidney toxicity of albumin

0

40

129

CJASN

@CJASN

1 year

The role of albumin in kidney injury remains controversial. Is it a marker of advancing glomerular injury, a marker of proximal tubule injury and disfunction or a combination of both? This Perspective examines recent studies on toxicity of albumin

0

48

126

CJASN

@CJASN

1 year

The application of continuous KRT varies due to a lack of standardization in how the treatments are prescribed, delivered, and optimized. This article presents an overview of the therapy, recent clinical trials, and outcome studies @UTSWNephrology

1

44

125

CJASN

@CJASN

1 year

KDIGO guidelines recommend following anti-PLA2R antibody levels as a marker of treatment response in membranous nephropathy. This study found the optimal method to evaluate risk factors for was to use anti-PLA2R antibody & albumin levels after 3 months

1

60

126

CJASN

@CJASN

2 years

Infections are a common complication of transplantation. This Review summarizes the current epidemiology of postkidney transplant infections, focusing on key viral, bacterial, and fungal infections, as well as guidelines for safe living post-transplant

1

52

124

CJASN

@CJASN

2 months

Lowering dialysate sodium concentration may improve volume & BP control in patients on maintenance hemodialysis. This study found use of a dialysate sodium concentration of 135 was linked to a small reduction in interdialytic weight gain @DanTheKidneyMan

1

50

125

CJASN

@CJASN

3 months

Nephrologists are frequently consulted when the cause of high anion gap metabolic acidosis is not readily apparent. This article presents a modified version of the CUTE DIMPLES mnemonic and its use in the evaluation of high anion gap metabolic acidosis

2

47

120

CJASN

@CJASN

10 months

Hematuria is frequently present in podocytopathies. This study found hematuria is prevalent among participants with the three podocytopathies and is significantly and independently associated with worse kidney-related outcomes

1

50

119

CJASN

@CJASN

10 months

Over the past several decades, the percentage of time that nephrologists spend caring for patients in ICUs has increased. Our Critical Care Nephrology and AKI Series covers broad aspects of critical care nephrology Read the completed collection: #jnlcoll

0

61

117

CJASN

@CJASN

2 years

Guidelines for systemic lupus erythematosus (SLE) recommend kidney biopsy at a urine protein-creatinine ratio of ≥0.5 g/g. In this study of patients with SLE & low-grade proteinuria, over half progressed to a urinary protein-creatinine ratio of ≥0.5 g/g

1

42

113

CJASN

@CJASN

2 years

Critically ill patients with cancer are at highest risk of developing AKI. This Review highlights the epidemiology of AKI in critically ill patients with cancer, risk factors for AKI, and common pathologies associated with certain cancer therapies

0

46

113

CJASN

@CJASN

2 years

While the definition of sepsis has evolved significantly in the past 30 years, early recognition & intervention remain hallmarks for sepsis management. This Critical Care Nephrology & Acute Kidney Injury article focuses on modern sepsis management methods

0

29

112

CJASN

@CJASN

5 years

Catch up on the @CJASN special series "Renal Immunology for the Clinician," now available for download in a compiled PDF here:

0

50

112

CJASN

@CJASN

2 years

Sepsis accounts for high morbidity, mortality, & economic burden. Early recognition & intervention are hallmarks for sepsis management. This Review discusses modern sepsis management methods & examines optimum initial resuscitation of patients with sepsis

1

45

109

CJASN

@CJASN

2 years

Diabetic kidney disease (DKD) is the most frequent cause of kidney failure, accounting for half of all cases worldwide. This article presents unmet needs for practice, policy, and research in DKD and strategies for improvement @ChristosArgyrop @DrLesWong

3

46

111

CJASN

@CJASN

7 months

Hematuria is frequently present in podocytopathies. This study shows hematuria is significantly and independently associated with worse kidney-related outcomes, including both progressive loss of kidney function and remission of proteinuria.

0

52

109

CJASN

@CJASN

3 years

Nephropharmacology for the Clinician: This series is a vital resource for the basic principles and considerations that are fundamentally important in the use of drugs in patients with kidney disease View the entire collection here:

0

41

109

CJASN

@CJASN

4 years

A meta-analysis found that although native kidney biopsy is an invasive diagnostic procedure, the rates of bleeding complications are low. Complications are more frequently seen after kidney biopsies of hospitalized patients with AKI.

1

44

108

CJASN

@CJASN

11 months

Diarrhea is a common complication after kidney transplantation, often presenting as a diagnostic challenge for clinicians. This Kidney Case Conference: Nephrology Quiz & Questionnaire presents a case of norovirus in a kidney transplant recipient

1

42

108

CJASN

@CJASN

2 years

Intravenous fluid administration is the mainstay for prevention for contrast-associated AKI. This study found that administration of a total volume of 1000 ml is associated with a similar risk of adverse outcomes as larger volumes of intravenous fluids

0

50

105

CJASN

@CJASN

4 years

A new study found that the kidney failure risk equation ( #KFRE ) provided adequate to excellent discrimination in identifying patients with CKD likely to progress to kidney failure at the 2- and 5-year time points both overall and across etiologies.

2

46

106

CJASN

@CJASN

1 year

Weighing the risks and benefits of clinical interventions is an everyday part of clinical practice. This article illustrates the decisions analysts must make when developing and evaluating risk prediction models, including the role of machine learning

0

33

105

CJASN

@CJASN

1 year

IgA nephropathy can progress to kidney failure. This study found that outcomes in a large IgA nephropathy cohort are generally poor with few patients expected to avoid kidney failure in their lifetime @DannyGale_1 @IgAN_JBarratt @Moinsaleem @neilturn

2

51

102

CJASN

@CJASN

1 year

IgG4-related kidney disease is a major manifestation of IgG4-related disease. This study found that IgG4-related kidney disease predominantly affected middle-aged males and manifested as tubulointerstitial nephritis with potential glomerular involvement

2

50

105

CJASN

@CJASN

2 years

Peritoneal dialysis (PD) as an AKI treatment in adults was widely accepted in critical care settings well into the 1980s. This article highlights advantages and disadvantages of PD in critical care settings and indications and contraindications for its use

0

49

102

CJASN

@CJASN

4 years

#Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications

3

48

102

CJASN

@CJASN

3 years

Dietary potassium restriction in people receiving maintenance hemodialysis is standard practice and is recommended in guidelines. This study assesses the link between dietary potassium intake and mortality and whether hyperkalemia mediates this link

1

49

102

CJASN

@CJASN

3 years

A “How I Treat” article summarizes a practical approach to initiating sodium-glucose transport protein 2 (SGLT2) inhibitors for people with type 2 diabetes and CKD based on the 2020 KDIGO Clinical Practice Guideline for Management of Diabetes in CKD.

0

29

102

CJASN

@CJASN

1 year

IgG4-related kidney disease is a major manifestation of IgG4-related disease. This study found IgG4-related kidney disease manifested as tubulointerstitial nephritis with potential glomerular involvement @audard15 @Mercadal17 @Olivier_Thaunat

1

53

101

CJASN

@CJASN

2 months

Liddle syndrome is a rare form of monogenic hypertension caused by gain-of-function variants in the epithelial Na+ channel (ENaC). This study found patients with genetically confirmed Liddle syndrome displayed a phenotypic spectrum

0

39

102

CJASN

@CJASN

2 years

Tolvaptan slows expansion of kidney volume and kidney function decline in adults with ADPKD. This study found that tolvaptan exhibited pharmacodynamic activity in pediatric ADPKD. Aquaretic effects were manageable, with few discontinuations

3

36

101

CJASN

@CJASN

3 years

A Review explores the theoretical benefits and risks of using intravenous albumin to mitigate intradialytic hypotension and/or enhance ultrafiltration. It summarizes the current evidence relating to this practice.

0

32

102

CJASN

@CJASN

2 years

SGLT2-inhibitor-induced uric acid lowering may contribute to kidney protective effects of the drug-class in people with type 2 diabetes. This study investigates mechanisms of plasma uric acid lowering by SGLT2-inhibitors in people with type 2 diabetes

0

34

99

CJASN

@CJASN

3 years

Fatigue is a common and debilitating symptom in patients with CKD. This Review consolidates information about the identification, epidemiology, pathophysiology, and potential treatments of fatigue in patients with CKD @UTSWNephrology

0

37

98

CJASN

@CJASN

3 years

CJASN is proud to share our 2021 Editors' Choice articles! These 5 articles exemplify the highest potential to inform future research, change clinical practice, or influence public policy. All are freely accessible until February 28

4

47

101

CJASN

@CJASN

2 years

Pseudo-hyperaldosteronism features hypokalemia, metabolic alkalosis, & suppressed renin. This Kidney Case Conference: How I Treat article presents a case of pseudo-hyperaldosteronism & review a schema for management @katierizzolo @NatNephro @sophia_kidney

0

40

97

CJASN

@CJASN

2 years

AKI among individuals with cirrhosis is common, and it has been occurring more frequently over the last two decades. This Critical Care Nephrology and Acute Kidney Injury article discusses the management of AKI in cirrhosis @VelezNephHepato

1

51

98

CJASN

@CJASN

1 year

SGLT2 inhibitors attenuate incident cardiovascular outcomes in conservatively managed CKD. This study found dapagliflozin was well tolerated and had nonaccumulating pharmacokinetic properties in patients with kidney failure on dialysis @LekaStaffico

0

47

99

CJASN

@CJASN

2 years

The pathogenesis of hyponatremia in endocrine disorders is complex & often oversimplified. In this Kidney Case Conference: Nephrology Quiz & Questionnaire, Drs @melhoenig & @StewartLecker discuss treating a patient with severe hyponatremia @BIDMChealth

1

45

97

CJASN

@CJASN

2 years

AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. This article discusses tailoring management of AKI in patients with liver disease to the specific underlying etiology @VelezNephHepato

0

35

96

CJASN

@CJASN

7 months

AKI secondary to light chain cast nephropathy is common in patients with multiple myeloma at presentation and a time-critical emergency. This Kidney Case Conference: How I Treat article describes an approach to this problem

1

39

98

CJASN

@CJASN

10 months

Crystalline nephropathies are an underdiagnosed cause of kidney disease characterized by intrarenal crystal deposition involving the tubulointerstitium. This Kidney Case Conference: How I Treat article proposes a practical approach to guide the diagnosis

0

44

98

CJASN

@CJASN

2 years

Sepsis-associated AKI is a life-threatening complication linked to high morbidity & mortality in patients who are critically ill. This article summarizes laboratory and clinical studies, focusing on factors in the pathophysiology of sepsis-associated AKI

0

47

95

CJASN

@CJASN

1 year

Thrombotic microangiopathies (TMAs) encompass a wide spectrum of ultra-rare diseases resulting from endothelial injury. This study shows secondary TMAs represent the main cause of TMA & are linked to high risk of death & progression to kidney failure

0

47

95

CJASN

@CJASN

1 year

Mg2+, the fourth most abundant cation in the body, serves as a cofactor for about 600 cellular enzymes. This Review focuses on the nature of transport in the gut and renal tubule and how they are integrated into an understanding of human Mg2+ physiology

1

39

94

CJASN

@CJASN

2 years

AKI is often multifactorial, especially in the hospitalized patient. This Review discusses the pathophysiology of three etiologies that cause AKI: kidney hypoperfusion, abdominal compartment syndrome, and urinary tract obstruction @IUKidney

1

42

91

CJASN

@CJASN

5 months

AKI is a common complication of rhabdomyolysis and is associated with high morbidity and mortality. This Kidney Case Conference: How I Treat article presents management strategies for rhabdomyolysis-induced AKI @javo_neyra

0

37

93

CJASN

@CJASN

2 years

ANCA-associated vasculitides affect the kidneys with aggressive inflammation. This Kidney Case Conference: How I Treat article discusses the use of rituximab in severe ANCA-associated glomerulonephritis, focusing on frail & elderly populations @BrixSilke

1

34

92

CJASN

@CJASN

2 years

AKI is a syndrome that is often multifactorial, especially in the hospitalized patient. This Review discusses the pathophysiology of three etiologies that cause AKI: kidney hypoperfusion, abdominal compartment syndrome, and urinary tract obstruction

0

43

91

CJASN

@CJASN

2 years

Inherited tubulopathies are characterized by impaired function of one or more of transport molecules. This Review discusses the genetic aspects of tubulopathies & how genetic investigations and kidney physiology have crossfertilized each other @CamyLG86

3

33

93

CJASN

@CJASN

1 year

Large-scale clinical trials have shown SGLT2 inhibitor prevents long-term kidney function decline and reduces the risks of adverse kidney outcomes. This study found several background medications were linked to the initial eGFR dip after SGLT2i initiation

1

46

91

CJASN

@CJASN

1 year

Diarrhea is a common complication after kidney transplantation with causes, often presenting as a diagnostic challenge for clinicians. This article presents a case of norovirus in a transplant recipient @kidneybeaN12zu @kidneyshower

3

39

91

CJASN

@CJASN

10 months

ADPKD is a genetic disorder characterized by kidney cyst formation and progressive kidney function loss. This Review discusses the available evidence supporting the efficacy and safety of dietary interventions in ADPKD @fouadchebib @KristenlNowak @ndahl48

1

43

90

CJASN

@CJASN

4 years

Medications that slow kidney failure and reduce heart diseases are under-prescribed for patients with diabetic kidney disease. A new study provides a prescription algorithm to guide the use of SGLT2i and GLP-1 RA.

1

52

88

CJASN

@CJASN

3 years

Diabetic kidney disease is a devastating complication of diabetes. This Review highlights advances in treatment, challenges, & solutions to advance kidney health, and introduces the launch of the Diabetic Kidney Disease Collaborative at ASN

1

44

87

CJASN

@CJASN

8 months

Tumor lysis syndrome results from the spontaneous or therapy-induced destruction of malignant cells, releasing intracellular content into extracellular space. This article discusses the presentation and treatment of tumor lysis syndrome

0

35

88

CJASN

@CJASN

2 years

How does the new KDIGO 2021 blood pressure guideline affect the management of BP in patients with CKD? This Kidney Case Conference: How I Treat article presents a case that takes these new guidelines into account @edgarvlermamd

0

31

86

CJASN

@CJASN

2 years

Individuals with congenital anomalies of the kidney and urinary tract (CAKUT) are an important patient category. This Review discusses the molecular etiology of CAKUT & the available genome diagnostic modalities in the clinical care of patients with CAKUT

0

34

88

CJASN

@CJASN

2 years

This study suggests that treatment with the combination of ACE inhibitors/ARB and SGLT2 inhibitor in patients with albuminuric CKD without diabetes could substantially increase kidney failure–free survival @DavidCWheeler2 @gchertow @BWHKidney

4

29

87

CJASN

@CJASN

2 years

Advances in cancer therapy have improved patient survival; however, AKI is common in patients with cancer. This Review highlights the epidemiology of AKI in critically ill patients with cancer, risk factors for AKI, & common pathologies linked to therapies

0

37

86

CJASN

@CJASN

1 year

Intermittent hemodialysis is a cornerstone of extracorporeal KRT in the ICU. This Critical Care Nephrology and AKI article reviews important aspects of the management of intermittent hemodialysis in patients who are critically ill @MarkCanney @edclark75

1

40

86

CJASN

@CJASN

1 month

The link between cardiac and kidney dysfunction has received increasing attention over the past two decades. This Review discusses the methodologic and practical problems inherent to the current classification of cardiorenal syndrome @ZoccaliCarmine

1

37

86

CJASN

@CJASN

2 years

Alport syndrome is the second most common cause of genetic kidney failure after polycystic kidney disease. This Review discusses digenic Alport syndrome, with a focus on the pathogenesis and management of different types of digenic inheritance

2

40

84

CJASN

@CJASN

2 years

Acid-base disorders are common in the ICU. By utilizing a systematic approach to their diagnosis, it is easy to identify both simple & mixed disturbances. This Review focuses on those disorders that occur in the critically ill

0

44

82

CJASN

@CJASN

4 months

Conversion to a belatacept-based immunosuppression is used as a calcineurin inhibitor (CNI) avoidance strategy. This study shows that conversion to belatacept post-transplant was associated with lower risk of graft failure and acceptable safety outcomes

0

30

84

CJASN

@CJASN

4 years

Peer review is integral to publishing high-quality, valid research. CJASN would like to recognize the top 5 reviewers of 2020: Dr. Ziyad Al-Aly, Dr. Raymond Hsu, Dr. Kenar Jhaveri, Dr. Matthew Rivara, and Dr. Deirdre Sawinski. Each day, we'll share their thoughts on peer review.

2

5

85